Therapeutic applications of serine protease inhibitors

about

Novel serine protease inhibitors.Effect of MCM09, an active site-directed inhibitor of factor Xa, on B16-BL6 melanoma lung colonies in mice.The sulfamide motif in the design of enzyme inhibitors.

P2860

Q38162937-580AA382-4CBF-493C-9C25-766FDBA5B743 Q40320314-71009BEE-F1CA-4A97-974D-0CCB7FE5CB64 Q43168863-CDB5D3B9-5E7B-4FAC-BEC4-ACEF38F070F4

P2860

Therapeutic applications of serine protease inhibitors

Item

http://www.wikidata.org/entity/Q58863311

description

im August 2002 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2002

@uk

name

Therapeutic applications of serine protease inhibitors

@en

Therapeutic applications of serine protease inhibitors

@nl

type

Item

label

Therapeutic applications of serine protease inhibitors

@en

Therapeutic applications of serine protease inhibitors

@nl

prefLabel

Therapeutic applications of serine protease inhibitors

@en

Therapeutic applications of serine protease inhibitors

@nl

P1476

Therapeutic applications of serine protease inhibitors

@en

P2093

Claudiu T Supuran

http://www.w3.org/2001/XMLSchema#string

Marc A Ilies

http://www.w3.org/2001/XMLSchema#string

P2860

(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase

Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa

X-ray snapshots of serine protease catalysis reveal a tetrahedral intermediate

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

Structure-based design of novel potent nonpeptide thrombin inhibitors

Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine, and ornithine analogs

Design and synthesis of potent and highly selective thrombin inhibitors

Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A

The crystal structure of the catalytic domain of human urokinase-type plasminogen activator

Three-dimensional structure of human cytomegalovirus protease

P304

1181-1214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.12.8.1181

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrea Scozzafava

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

Therapeutic applications of serine protease inhibitors

about

P2860

P2860

Therapeutic applications of serine protease inhibitors

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577